Doh-ura K - Search Results

1

Amyloid-binding compounds and their anti-prion potency.

Teruya K, Doh-ura K. Teruya K, et al. Curr Top Med Chem. 2013;13(19):2522-32. doi: 10.2174/15680266113136660178. Curr Top Med Chem. 2013. PMID: 24059333 Review.

2

Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner.

Kawasaki Y, Kawagoe K, Chen CJ, Teruya K, Sakasegawa Y, Doh-ura K. Kawasaki Y, et al. J Virol. 2007 Dec;81(23):12889-98. doi: 10.1128/JVI.01563-07. Epub 2007 Sep 19. J Virol. 2007. PMID: 17881452 Free PMC article.

3

Amyloidophilic compounds for prion diseases.

Teruya K, Kawagoe K, Kimura T, Chen CJ, Sakasegawa Y, Doh-ura K. Teruya K, et al. Infect Disord Drug Targets. 2009 Feb;9(1):15-22. doi: 10.2174/1871526510909010015. Infect Disord Drug Targets. 2009. PMID: 19200011 Review.

4

Efficacy and mechanism of a glycoside compound inhibiting abnormal prion protein formation in prion-infected cells: implications of interferon and phosphodiesterase 4D-interacting protein.

Nishizawa K, Oguma A, Kawata M, Sakasegawa Y, Teruya K, Doh-ura K. Nishizawa K, et al. J Virol. 2014 Apr;88(8):4083-99. doi: 10.1128/JVI.03775-13. Epub 2014 Jan 22. J Virol. 2014. PMID: 24453367 Free PMC article.

5

Structure-activity analysis and antiprion mechanism of isoprenoid compounds.

Hamanaka T, Nishizawa K, Sakasegawa Y, Teruya K, Doh-ura K. Hamanaka T, et al. Virology. 2015 Dec;486:63-70. doi: 10.1016/j.virol.2015.09.002. Epub 2015 Sep 22. Virology. 2015. PMID: 26402376 Free article.

6

Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.

Hamanaka T, Nishizawa K, Sakasegawa Y, Oguma A, Teruya K, Kurahashi H, Hara H, Sakaguchi S, Doh-Ura K. Hamanaka T, et al. J Virol. 2017 Feb 28;91(6):e01862-16. doi: 10.1128/JVI.01862-16. Print 2017 Mar 15. J Virol. 2017. PMID: 28077650 Free PMC article.

7

Pyrene conjugation and spectroscopic analysis of hydroxypropyl methylcellulose compounds successfully demonstrated a local dielectric difference associated with in vivo anti-prion activity.

Teruya K, Oguma A, Nishizawa K, Kamitakahara H, Doh-Ura K. Teruya K, et al. PLoS One. 2017 Sep 21;12(9):e0185357. doi: 10.1371/journal.pone.0185357. eCollection 2017. PLoS One. 2017. PMID: 28934337 Free PMC article.

8

Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction.

Teruya K, Nishizawa K, Oguma A, Sakasegawa Y, Kitamoto T, Doh-Ura K. Teruya K, et al. Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):384-394. doi: 10.1016/j.bbagen.2018.11.008. Epub 2018 Nov 14. Biochim Biophys Acta Gen Subj. 2019. PMID: 30447252

9

Activities of curcumin-related compounds in two cell lines persistently infected with different prion strains.

Teruya K, Iwabuchi S, Watanabe Y, Tsuchida R, Watanabe-Matsui M, Konno H, Doh-Ura K. Teruya K, et al. Among authors: doh ura k. Biochim Biophys Acta Gen Subj. 2022 Apr;1866(4):130094. doi: 10.1016/j.bbagen.2022.130094. Epub 2022 Jan 19. Biochim Biophys Acta Gen Subj. 2022. PMID: 35065183

10

GABAA receptor subunit beta1 is involved in the formation of protease-resistant prion protein in prion-infected neuroblastoma cells.

Kimura T, Ishikawa K, Sakasegawa Y, Teruya K, Sata T, Schätzl H, Doh-ura K. Kimura T, et al. FEBS Lett. 2010 Mar 19;584(6):1193-8. doi: 10.1016/j.febslet.2010.02.029. Epub 2010 Feb 14. FEBS Lett. 2010. PMID: 20159020 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters